Bone Biologics Corp (BBLG)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | MEIKLE, PHILLIP TERRY II | Director | Non-Employee Stock Option | Acquisition | 113,896 | $0 |
| Sep 28, 2026 | GAGNON, ROBERT E. | Director | Non-Employee Stock Option | Acquisition | 113,896 | $0 |
| Sep 28, 2026 | STROEVER, BRUCE | Director | Non-Employee Stock Option | Acquisition | 113,896 | $0 |
| Sep 28, 2026 | ANGLE, SIDDHESH RAJENDRA | Director | Non-Employee Stock Option | Acquisition | 113,896 | $0 |
| Jan 8, 2026 | FRELICK, JEFF | Chief Executive Officer | Employee Stock Option | Acquisition | 16,668 | $0 |
| Jan 8, 2026 | WALSH, DEINA H | Chief Financial Officer | Employee Stock Option | Acquisition | 8,335 | $0 |